NCMAG114 Raloxifene advice document: October 2024
Posted on:
Document Type
NCMAG advice
Process guidance
Summary
The primary prevention of breast cancer in post-menopausal people at moderate or high risk who are not suitable for on-label alternatives. Off-label use and off-patent medicine.
Decision: supported